Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
GLENMARK Pharmaceuticals said on Monday its unit entered an outof-court settlement with Glaxo-SmithKline LLC over patent actions on doses of atovaquone and proguanil hydrochloride, the generic version of GSK
P B Jayakumar / Mumbai April 6, 2010, 0:47 IST Piramal Healthcare, one among the top five domestic pharmaceutical companies, plans to acquire more drug brands and diagnostics chains to expand its footprint across India. Murari Rajan Ajay Piramal-led Piramal Healthcare, which recently bought emergency contraceptive brand i-Pill from Cipla …
The EU-India agreement might not stop generic drug seizures at European portsJust a few months ago, Indian officials were up in arms against the European Union (EU) after several generic drug consignments en route to Latin America and Africa had been seized by EU customs. Subsequently, commerce ministry officials vowed …
Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies Several civil society groups have come together to question the commerce and industry ministry
TK ARUN STEFAN Oschmann is president, Emerging Markets, at Merck, the world's second largest pharmaceuticals company after its 2009 merger with Schering-Plough, with a combined global revenue in 2009 of $27.4 billion. Now, if that doesn't look very large these days, with the individual worth of each of the top …
GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer
RANBAXY Laboratories on Monday announced it has settled a patent dispute with Takeda Pharmaceutical allowing the Gurgaon-based drugmaker to launch its generic tablets of Takeda
The Delhi High Court refused a patent linkage to multinational pharma company Bayer’s for its cancer drug sorefenib tosylate, sold under the name Nexavar. This means there is no restriction on the drug controller to approve generic versions of patent drugs. Bayer holds the patent for sorenfenib, used to treat …
Ahmedabad: Leading UK drugmaker AstraZeneca Plc will brand and market 18 medicines manufactured by the Rs 1,600-crore Ahmedabad-based pharma company Torrent Pharmaceuticals in 9 emerging economies. AstraZeneca follows UK peer GlaxoSmithKline Plc and Sanofi-Aventis SA of France in its foray into the growing market for lowerpriced copied medicines as drugmakers …
Chennai: Nearly $60 billion worth of patents for drugs is set to expire in the next four years across the world and Indian pharmaceutical companies are now in a position to take a major share of this pie, industry members said. Already, India is the No. 1 exporter of generic …
THE financial meltdown may be history, but its effects continue to haunt, especially when it comes to corporate innovations. A case in point is the dip in the number of patent filings in India in 2009-10. According to the Controller General of Patents, Designs & Trade Marks, the number of …
CEO Says Pharma Major Plans To Invest Rs 430 Cr To Develop Vaccines Here GLAXOSMITHKLINE (GSK) would cut retail prices in India to cater to the lower-income segment besides pumping in Rs 430 crore to develop vaccines from its local facilities, according to Andrew Witty, global CEO of the world
New Delhi: Clinical trials in India are finally becoming transparent. There has been a dramatic increase in the number of trials that have got officially registered in Clinical Trials Registry-India (CTRI). According to records collected by the Indian Council of Medical Research and the Drug Controller General
There is an ongoing debate about the rationality of price controls in a regime where drugs can be manufactured through alternative processes as was the case in India before 2005. In a regime of only process patents, competition was expected to bring prices down. However, even when there was an …
THE Supreme Court (SC) on Friday turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer
A trial of a new oral cholera vaccine in Kolkata is promising but, as Patralekha Chatterjee reports, a vaccine is only one weapon in the battle against the disease.
